1. Abstract Helapharm has recently discovered a new peptide that shows signs of a viable anti-obesity treatment. Helapharm has enough funding to get them through the next six months, but will not have enough money to fund the majority of the project. The pre-clinical development phase, clinical validation phase, and drug launch phase are three major phases that need additional funds for the successful launch of this novel drug. Helapharm has created this project plan outlining key milestones, timeline…
Words 3290 - Pages 14